Literature DB >> 21392721

Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage?

Palaniappan Manickam1, Ankit Rathod, Sidakpal Panaich, Pawan Hari, Vikas Veeranna, Apurva Badheka, Sony Jacob, Luis Afonso.   

Abstract

BACKGROUND: Comparative data on the prognostic utility of novel lipid parameters vs. conventional lipid parameters in predicting coronary events are scant.
OBJECTIVE: We sought to compare the predictive value of various lipid measures for coronary events and to further examine the incremental value of novel lipid parameters over traditional cardiovascular risk factors in estimating cardiac risk.
METHODS: We performed a post-hoc analysis of the National Heart Lung and Blood Institute limited access dataset of Multi-Ethnic Study of Atherosclerosis subjects (n = 6693). The lipid measures considered in the estimation of coronary risk were conventional and novel lipid parameters, the latter included total low-density lipoprotein (LDL), high-density lipoprotein (HDL) and very low-density lipoprotein (VLDL)-particle concentrations (LDL-p, HDL-p and VLDL-p), LDL-p/HDL-p ratio, and LDL-p subfractions. The outcome measured was occurrence of any coronary event (CE) that included myocardial infarction, resuscitated cardiac arrest, cardiac death, and angina.
RESULTS: During an average follow up of 4.5 years, 228 patients developed coronary events. In the multivariate Cox proportional hazards model, TC/HDL-c (HR: 3.27; 95% CI: 1.95 to 5.47, P < .0001) was a stronger predictor of CE. Among the novel lipid parameters, LDL-p/HDL-p (hazard ratio 2.84; 95% confidence interval 1.89 to 4.26; P < .0001) was a powerful independent predictor of CE. The c-statistics were similar for both LDL-p/HDL-p and TC/HDL-c ratios (0.60). The addition of LDL-p/HDL-p ratio to the Framingham risk score components resulted in a very small increase in the overall C statistic.
CONCLUSION: In our large study cohort, a predictive model for future coronary events incorporating the best-available novel lipid parameter (LDL-p/HDL-p ratio) was comparable with the same model that incorporated conventional lipid ratios such as the TC/HDL-c ratio . The use of LDL-p/HDL-p ratio did not appear to offer incremental value over more traditional risk prediction models.
Copyright © 2011 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21392721     DOI: 10.1016/j.jacl.2010.12.001

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  10 in total

1.  Dyslipidemia and non-alcoholic fatty liver disease.

Authors:  Palaniappan Manickam; Rajeev Sudhakar
Journal:  Dig Dis Sci       Date:  2013-03-19       Impact factor: 3.199

2.  Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients.

Authors:  Lisa Kakinami; Michael J Adams; Robert C Block; Susan E Cohn; Benedict Maliakkal; Susan G Fisher
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-10       Impact factor: 2.205

3.  Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).

Authors:  Mohamed B Elshazly; Renato Quispe; Erin D Michos; Allan D Sniderman; Peter P Toth; Maciej Banach; Krishnaji R Kulkarni; Josef Coresh; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  Circulation       Date:  2015-07-02       Impact factor: 29.690

4.  Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population.

Authors:  Guotai Sheng; Maobin Kuang; Ruijuan Yang; Yanjia Zhong; Shuhua Zhang; Yang Zou
Journal:  J Transl Med       Date:  2022-06-11       Impact factor: 8.440

Review 5.  Cardiovascular Risk Assessment in the Older Athlete.

Authors:  Alec J Moorman; Larry S Dean; Eugene Yang; Jonathan A Drezner
Journal:  Sports Health       Date:  2021-03-18       Impact factor: 3.843

6.  Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Brian T Steffen; Weihua Guan; Alan T Remaley; Pathmaja Paramsothy; Susan R Heckbert; Robyn L McClelland; Philip Greenland; Erin D Michos; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12-04       Impact factor: 8.311

7.  Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review.

Authors:  Majambu Mbikay
Journal:  Front Pharmacol       Date:  2012-03-01       Impact factor: 5.810

8.  Total serum cholesterol, atherogenic indices and their longitudinal association with depressive symptoms among US adults.

Authors:  M A Beydoun; H A Beydoun; G A Dore; M T Fanelli-Kuczmarski; M K Evans; A B Zonderman
Journal:  Transl Psychiatry       Date:  2015-03-03       Impact factor: 6.222

9.  Does pregnancy alter life-course lipid trajectories? Evidence from the HUNT Study in Norway.

Authors:  Amanda R Markovitz; Eirin B Haug; Julie Horn; Abigail Fraser; Corrie Macdonald-Wallis; Kate Tilling; Eric B Rimm; Stacey A Missmer; Paige L Williams; Pål R Romundstad; Bjørn O Åsvold; Janet W Rich-Edwards
Journal:  J Lipid Res       Date:  2018-10-12       Impact factor: 5.922

10.  Anti-hypercholesterolemic Effect of Berbamine Isolated from Rhizoma Coptidis in Hypercholesterolemic Zebrafish Induced by High-Cholesterol Diet.

Authors:  Bing Han; Shuming Kou; Kai He; Yulong Han; Yue Wang; Tao Huang; Xia Zhou; Yubo Xiao; Xuegang Li; Xiaoli Ye
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.